SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare informs about conference call

23 Oct 2021 Evaluate

Cadila Healthcare has informed that financial results of the company for Q2 2021-22 (July-September 2021) would be declared on October 29, 2021. Post results Q&A session through teleconference has been scheduled on the same day October 29, 2021 at 4:00 pm. Sharvil Patel, Managing Director of the Company would be hosting the call. The call will be conducted through the audio webcast format. The link to join the call is attached.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1157.10 -2.75 (-0.24%)
10-Jul-2026 12:24 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1937.05
Dr. Reddys Labs. 1247.55
Cipla 1444.05
Zydus Lifesciences 1157.10
Lupin 2508.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: